Small molecule inhibitors of mRNA translation initiation for treating cancer
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT06792734
Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 14, 2025
Completion: Dec 31, 2027
Loading map...